![Karen B. Chapman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Karen B. Chapman is the founder of Origen Therapeutics, Inc. She worked as the Vice President-Research at OncoCyte Corp.
from 2011 to 2017.
Chapman holds a graduate degree from Cornell University and a doctorate degree from The Johns Hopkins University School of Medicine, which she received in 1991.
Former positions of Karen B. Chapman
| Companies | Position | End |
|---|---|---|
| INSIGHT MOLECULAR DIAGNOSTICS INC. | Chief Tech/Sci/R&D Officer | 21/03/2017 |
Origen Therapeutics, Inc.
 Origen Therapeutics, Inc. BiotechnologyHealth Technology Operates biotechnology company, develops products from avian transgenic animal technology | Founder | - |
Training of Karen B. Chapman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
19
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Origen Therapeutics, Inc.
Origen Therapeutics, Inc. BiotechnologyHealth Technology Operates biotechnology company, develops products from avian transgenic animal technology | Health Technology |
OncoCyte Corp.
 OncoCyte Corp. BiotechnologyHealth Technology Focuses on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer | Health Technology |
The Johns Hopkins University School of Medicine
 The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Karen B. Chapman
